Panayiota Trifillis

Title: Panayiota Trifillis: Innovator in Gene Expression Modulation

Introduction

Panayiota Trifillis is a notable inventor based in Piscataway, NJ (US). She has made significant contributions to the field of gene expression modulation, holding a total of four patents. Her work focuses on innovative methods that enhance our understanding of gene regulation.

Latest Patents

Among her latest patents is a method for identifying compounds that modulate untranslated region-dependent gene expression. This invention relates to using untranslated regions of a target gene or fragments linked to a reporter gene to identify compounds that can influence gene expression. The methods provide a simple and sensitive assay for high-throughput screening of compound libraries to identify potential pharmaceutical leads. Another significant patent involves methods and agents for screening compounds capable of modulating gene expression. This invention includes assays designed to screen for agents that can alter gene expression in a UTR-dependent manner.

Career Highlights

Panayiota Trifillis is currently associated with PTC Therapeutics, Inc., where she continues to advance her research in gene expression. Her work has been instrumental in developing new approaches to understanding and manipulating gene regulation.

Collaborations

She collaborates with esteemed colleagues, including Liangxian Cao and Nikolai A Naryshkin, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Panayiota Trifillis is a pioneering inventor whose work in gene expression modulation is paving the way for new therapeutic strategies. Her contributions are vital to the ongoing advancements in biotechnology and pharmaceutical development.